|Mr. Zheng Liang||CFO & Financial Director||N/A||N/A||1979|
|Mr. Jin Yuan Wang||VP||N/A||N/A||N/A|
|Ms. Hui Zhou||VP, Sec. of the Board of Directors & Director||N/A||N/A||1972|
|Mr. Yi Mai||VP||N/A||N/A||1967|
|Mr. Yanfei Wang||Assistant Pres||N/A||N/A||N/A|
|Mr. Bingxiang Zhao||Pres & Non-Independent Director||N/A||N/A||1973|
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. researches and develops, produces, and sells pharmaceutical products in the People's Republic of China and internationally. It also provides related health services. The company offers OTC products, including cold, skin, gastrointestinal, cough relieving, orthopedics, and pediatrics drugs; prescription drug products in traditional Chinese medicine, tumors, cardiovascular and cerebrovascular, digestive system, orthopedics, and pediatrics; Chinese medicine injections; formula granules; and anti-infective drugs. It sells its products under 999 family medicine brands, Sanjiuweitai series, 999 Ganmaoling series, 999 dermatitis series, and other products. The company was formerly known as Sanjiu Pharmaceutical Co., Ltd. and changed its name to China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. in February 2010. The company was founded in 1999 and is based in Shenzhen, the People's Republic of China. China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. is a subsidiary of China Resources (Holdings) Co., Ltd.
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.